Losartan and Ultravist drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 10 people who take Losartan and Ultravist. Common interactions include cardiac disorder among females, and erythema among males.

The phase IV clinical study analyzes what interactions people who take Losartan and Ultravist have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 24, 2023

10 people who take Losartan and Ultravist together, and have interactions are studied.

What is Losartan?

Losartan has active ingredients of losartan potassium. It is used in high blood pressure. Currently, eHealthMe is studying from 164,828 Losartan users.

What is Ultravist?

Ultravist has active ingredients of iopromide. Currently, eHealthMe is studying from 8,677 Ultravist users.

Number of Losartan and Ultravist reports submitted per year:

Common Losartan and Ultravist drug interactions by gender *:

female:

Cardiac disorder
Chills
Compartment syndrome
Death
Depressed level of consciousness
Fatigue
Generalised erythema
Hypersensitivity
Hypotension
Hypoxia

male:

Erythema
Pruritus
Type ii hypersensitivity
Cardiac failure
Hypoxia
Vomiting

Common Losartan and Ultravist drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Erythema
Pruritus
Type ii hypersensitivity

50-59:

n/a

60+:

Erythema
Hypoxia
Depressed level of consciousness
Fatigue
Generalised erythema
Hypersensitivity
Hypotension
Laryngeal oedema
Leukopenia
Malaise

Common conditions people have *:

Rectal Cancer (cancer of rectum): 1 person, 10.00%
Computerised Tomogram Abdomen: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan and Ultravist?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .

Related studies

Drug side effects by duration, gender and age:

Losartan side effects (164,828 reports)
Ultravist side effects (8,677 reports)

Common Losartan drug interactions:

Losartan and Aspirin: 30,004 reports
Losartan and Amlodipine: 27,210 reports
Losartan and Metformin: 23,444 reports
Losartan and Omeprazole: 22,108 reports
Losartan and Furosemide: 16,164 reports
Losartan and Simvastatin: 15,348 reports
Losartan and Vitamin d: 15,272 reports
Losartan and Zide: 15,231 reports
Losartan and Hydrochlorothiazide: 15,181 reports
Losartan and Gabapentin: 14,453 reports

Browse interactions between Losartan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ultravist drug interactions:

Browse interactions between Ultravist and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium and iopromide (the active ingredients of Losartan and Ultravist, respectively), and Losartan and Ultravist (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Losartan and Ultravist.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Eliquis and Heart Rate Decreased - a second ago
Glycopyrrolate and Trelegy Ellipta drug interaction - 11 seconds ago
Zanaflex and Snoring - 20 seconds ago
Neulasta and Miconazole Nitrate drug interaction - 31 seconds ago
Protonix and Mvasi drug interaction - 36 seconds ago
Ayvakit and Sjogren Syndrome - 40 seconds ago
Mycophenolate Mofetil and Nalbuphine drug interaction - 50 seconds ago
Hctz and Enoxaparin Sodium drug interaction - a minute ago
Riluzole and Mirapex drug interaction - a minute ago
Naproxen Sodium and Blood Parathyroid Hormone Decreased - a minute ago